Ticker > Company >

Astal Laboratories share price

Astal Laboratories Ltd.

BSE: 512600 SECTOR: Trading  5317   4   0

77.02
+3.66 (4.99%)
BSE: Today, 03:40 PM

Price Summary

Today's High

₹ 77.02

Today's Low

₹ 71

52 Week High

₹ 131.7

52 Week Low

₹ 37.09

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

75.71 Cr.

Enterprise Value

69.95 Cr.

No. of Shares

0.98 Cr.

P/E

15.98

P/B

2.57

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  29.97

CASH

6.08 Cr.

DEBT

0.31 Cr.

Promoter Holding

19.93 %

EPS (TTM)

₹  4.82

Sales Growth

589.82%

ROE

5.51 %

ROCE

7.62%

Profit Growth

4684.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year589.82%
3 Year∞%
5 Year∞%

Profit Growth

1 Year4684.76%
3 Year407.03%
5 Year63.14%

ROE%

1 Year5.51%
3 Year1.83%
5 Year1.01%

ROCE %

1 Year7.62%
3 Year2.64%
5 Year1.51%

Debt/Equity

0.0134

Price to Cash Flow

-13.54

Interest Cover Ratio

91.55

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2024 19.93 0.00
Sep 2024 19.93 0.00
Jun 2024 19.93 0.00
Mar 2024 19.93 0.00
Dec 2023 39.79 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 407.032409659418% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 91.55.
  • Company’s PEG ratio is 0.00871805599902705.
  • The company has an efficient Cash Conversion Cycle of 31.8804 days.
  • Company has a healthy liquidity position with current ratio of 2.0546.

 Limitations

  • Company has a poor ROE of 1.83197892086226% over the past 3 years.
  • Company has a poor ROCE of 2.63727777749829% over the past 3 years
  • Company has negative cash flow from operations of -5.5901.
  • The company has a low EBITDA margin of 0.1324% over the past 5 years.
  • The company is trading at a high PE of 15.98.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 12.25 8.41 12.25 13.15 13.16
Total Expenditure 11.67 7.92 11.67 10.77 10.27
Operating Profit 0.58 0.5 0.58 2.38 2.89
Other Income 0 0 0 0.03 0
Interest 0 0 0 0.06 0.09
Depreciation 0.02 0.01 0.02 0.01 0.03
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.56 0.49 0.56 2.34 2.77
Tax 0 0 0 0.65 0.77
Profit After Tax 0.56 0.49 0.56 1.69 2
Adjusted EPS (Rs) 0.57 0.99 0.57 1.72 2.04

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0 3.43 23.65
Total Expenditure 0.22 0.18 0.21 3.57 22.53
Operating Profit -0.22 -0.18 -0.21 -0.14 1.11
Other Income 0.2 0.2 0.21 0.18 0.01
Interest 0 0 0 0 0.01
Depreciation 0.02 0.02 0.01 0.01 0.03
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.03 0.01 -0.02 0.03 1.09
Tax 0 0 0 0.02 0.3
Net Profit -0.03 0.01 -0.02 0.02 0.78
Adjusted EPS (Rs.) -0.07 0.02 -0.04 0.04 0.8

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.99 3.99 3.99 3.99 9.85
Total Reserves 1.18 1.19 1.17 1.19 13.49
Borrowings 0 0 0 0 0.26
Other N/C liabilities 0 0 -0.01 0 0.01
Current liabilities 0.1 0.13 0.07 4.73 13.01
Total Liabilities 5.27 5.3 5.22 9.91 36.61
Assets
Net Block 0.07 0.05 0.01 0.01 0.69
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 5.11 3.79 9.2
Other N/C Assets 0.07 0.07 0 0 0
Current Assets 5.13 5.18 0.1 6.11 26.73
Total Assets 5.27 5.3 5.22 9.91 36.61
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.03 0.01 -0.02 0.03 1.09
Adjustment -0.19 -0.19 -0.2 -0.17 0.02
Changes in Assets & Liabilities 0.02 0 -0.04 -1.29 -6.66
Tax Paid 0 0 0 -0.01 -0.03
Operating Cash Flow -0.2 -0.19 -0.25 -1.44 -5.59
Investing Cash Flow 0.2 0.2 0.24 1.5 -6.11
Financing Cash Flow 0 0 0 0 17.69
Net Cash Flow 0.01 0.02 -0.01 0.07 5.99

Corporate Actions

Investors Details

PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024% Dec 2024%
promoters 39.79 19.93 19.93 19.93 19.93
aceso research labs llp 39.79 19.93 19.93 19.93 19.93
PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024% Dec 2024%
investors 60.21 80.07 80.07 80.07 80.07
badarinarayana venkata me... - 1.02 1.02 1.02 1.02
bosco armando menezes - 1.34 1.34 1.34 1.02
emily bosco menezes - 1.22 1.22 1.22 1.02
gandharva financial servi... 2.94 1.48 1.48 1.48 1.48
ganesh kumar . - - - 1.30 2.85
gayathri radhakrishnan - 1.02 1.02 1.02 1.02
goondla jyothi - 1.02 1.02 1.02 1.02
hari kishan bhonagiri - 1.02 1.02 1.02 1.02
jnv suresh kumar - 1.02 1.02 1.02 1.02
kamalakara rao yechuri - 2.54 2.54 2.54 2.54
lekhya entertainment pvt ... - 3.05 3.05 3.05 3.05
lenus finvest private lim... - 1.02 1.02 1.02 1.02
mallikarjun gada - 1.02 1.02 1.02 1.02
pavani vupparapalli 3.05 1.53 1.53 1.53 1.53
radha krishna doradla 4.06 3.56 3.56 3.56 3.56
ramamurty venkata bhaskar... - 1.53 1.53 1.53 1.53
ramaswamy anand . - 1.02 1.02 1.02 1.02
sana rambabu . 2.03 1.53 1.53 1.53 1.53
sannareddy suresh babu - 1.02 1.02 1.02 1.02
satyavani meduri - 3.56 3.56 3.56 1.78
siva nageswara rao doradl... 2.84 1.42 1.42 1.42 1.42
soma sree harsha - - - - 1.78
venkata padmavathi yechur... - 2.54 2.54 2.54 2.54
vupparapalli chandrasekha... 3.05 1.53 1.53 1.53 1.53
ashok dama - 1.02 1.02 1.02 -
kotha vamsi prasad - 1.02 1.02 1.02 -
narayana marthi venkata l... - 1.12 1.12 1.12 -
r lakshmi shobha 2.44 1.22 1.22 1.05 -
arati gattu 1.62 - - - -
dornadula nandini 1.02 - - - -
g ravi kumar ramanadham 1.62 - - - -
gnana prakash gattu 1.02 - - - -
kamlesh natwarlal shah 1.74 - - - -
kanta devi samdaria 1.13 - - - -
rakesh palakurthi 1.02 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Astal Laboratories informs about disclosures 2 Dec, 3:19 PM Astal Laboratories informs about disclosures 2 Dec, 3:18 PM Astal Laboratories informs about disclosure 29 Nov, 4:21 PM Astal Laboratories acquires Pharmaceutical Intermediates Manufacturing Plant in Karnataka 17 Oct, 9:59 AM Astal Laboratories informs about analyst meeting 7 Oct, 5:16 PM Astal Laboratories - Quaterly Results 27 Jul, 5:45 PM Astal Laboratories - Quaterly Results 27 Jul, 5:45 PM Astal Laboratories - Quaterly Results 27 Jul, 5:45 PM Macro International informs about change in directorate 25 May, 2:26 PM Astal Laboratories - Quaterly Results 24 May, 8:11 PM Astal Laboratories - Quaterly Results 24 May, 8:11 PM Macro International informs about disclosure 13 Feb, 10:51 AM Macro International - Quaterly Results 9 Feb, 4:06 PM Macro International - Quaterly Results 9 Feb, 4:06 PM Macro International - Quaterly Results 9 Feb, 4:06 PM Macro International informs about disclosure 30 Nov, 5:00 PM Macro International informs about scrutinizer’s report 20 Sep, 2:41 PM Macro International enters into Contrast media business 25 Aug, 12:47 PM Macro International informs about disclosure 11 Aug, 1:53 PM Macro International - Quaterly Results 15 Jul, 6:21 PM Macro International - Quaterly Results 15 Jul, 6:21 PM Macro International - Quaterly Results 15 Jul, 6:21 PM Macro (International) Exports informs about cut- off date for e-voting 24 Dec, 3:30 PM Macro (International) Exports informs about notice of first EGM of company 24 Dec, 3:23 PM Macro (International) Exports informs about newspaper publication 20 Sep, 4:29 PM Macro International informs about disclosure 16 Aug, 10:09 AM Macro (International) Exports informs about board meeting intimation 5 Aug, 4:16 PM Macro (International) Exports informs about PCS certificate 14 Apr, 4:35 PM Macro International - Quaterly Results 8 Feb, 2:24 PM Macro International - Quaterly Results 8 Feb, 2:24 PM Macro International - Quaterly Results 8 Feb, 2:24 PM Macro International informs about outcome of board meeting 10 Nov, 4:06 PM Macro International informs about proceedings of 28th AGM 27 Sep, 12:30 PM Macro International board to approve audited financial result 22 Jun, 5:11 PM Macro International informs about outcome of board meeting 2 Mar, 4:10 PM Macro International to hold board meeting 24 Feb, 1:15 PM

Astal Laboratories Stock Price Analysis and Quick Research Report. Is Astal Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Astal Laboratories stock price today is Rs 77.02. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Astal Laboratories . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Astal Laboratories has a PE ratio of 15.9795846386854 which is high and comparatively overvalued .

  • Share Price: - The current share price of Astal Laboratories is Rs 77.02. One can use valuation calculators of ticker to know if Astal Laboratories share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Astal Laboratories has ROA of 3.3736 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Astal Laboratories has a Current ratio of 2.0546 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Astal Laboratories has a ROE of 5.5095 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Astal Laboratories has a Debt to Equity ratio of 0.0134 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Astal Laboratories has reported revenue growth of 589.8194 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Astal Laboratories for the current financial year is 4.71377766125246 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Astal Laboratories is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Astal Laboratories is Rs 4.8199 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Astal Laboratories in Ticker for free. Also, one can get the intrinsic value of Astal Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Astal Laboratories
X